➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Harvard Business School
Baxter
Express Scripts
McKinsey
Johnson and Johnson

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

FELBAMATE - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Drug Prices for FELBAMATE

See drug prices for FELBAMATE

Recent Clinical Trials for FELBAMATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Instituto Nacional de Salud Publica, MexicoPhase 3
Laboratorios Grossman, S.A.Phase 3
Federal University of São PauloPhase 4

See all FELBAMATE clinical trials

Pharmacology for FELBAMATE

US Patents and Regulatory Information for FELBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993 AB RX Yes Yes   Start Trial   Start Trial   Start Trial
Alvogen FELBAMATE felbamate TABLET;ORAL 204595-001 Jan 11, 2016 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms FELBAMATE felbamate TABLET;ORAL 201680-002 Sep 13, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Amneal Pharms FELBAMATE felbamate TABLET;ORAL 201680-001 Sep 13, 2011 AB RX No No   Start Trial   Start Trial   Start Trial
Cadila FELBAMATE felbamate TABLET;ORAL 208970-001 May 30, 2017 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for FELBAMATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate SUSPENSION;ORAL 020189-003 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-002 Jul 29, 1993   Start Trial   Start Trial
Mylan Speciality Lp FELBATOL felbamate TABLET;ORAL 020189-001 Jul 29, 1993   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Medtronic
Boehringer Ingelheim
McKinsey
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.